The latest version of ProFound AI for DBT, version 3.0, was recently cleared by the FDA in March 2021. Compared to previous versions of the software, the ProFound AI 3.0 algorithm offers up to an additional 10 percent improvement in specificity performance and up to an additional 1 percent improvement in sensitivity over its previous deep-learning AI software generation (ProFound AI Version 2.1).[2] ProFound AI version 3.0 also offers up to 40 percent faster processing on the new PowerLook platform.2 ProFound AI version 3.0 was developed using over five million images from 30,000 cases, including almost 8,000 biopsy-proven cancers, and validated on approximately one million images from 3,500 cases that included 1,200 biopsy-proven cancers.
iCAD's Breast Health Solutions suite also includes software to evaluate breast density, ProFound AI for 2D Mammography, and ProFound AI Risk, the world's first and only clinical decision support tool that provides an accurate two-year breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.[3]
Ad Statistics
Times Displayed: 79541
Times Visited: 2807 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.
Back to HCB News
